The 2025 guideline introduces notable updates including refined recommendations for dual antiplatelet therapy, cardiogenic ...

Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...

Tiffany Meng, PharmD, oncology pharmacist, UCSF Health, discusses ways that pharmacists can help guide patients to financial ...

Mile Brujic, OD, FAAO, discusses his new research being presented at the Southeastern Educational Congress of Optometry 2025 ...

Selective laser trabeculoplasty, artificial intelligence–driven diagnostics, and new drug delivery systems are transforming ...

Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage ...

During the Southeastern Educational Congress of Optometry (SECO) 2025 meeting held from February 27 to March 2, 2025, in ...

Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with ...

Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes ...

Food recalls numbered 300 in 2024, indicating that increased vigilance may be required from both consumers and the FDA.

The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to ...

Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), especially in ...